Ghrelin, leptin, adiponectin, and insulin levels and concurrent and future weight change in overweight, postmenopausal women
- PMID: 21449093
- PMCID: PMC3069721
- DOI: 10.1097/gme.0b013e3181f2e611
Ghrelin, leptin, adiponectin, and insulin levels and concurrent and future weight change in overweight, postmenopausal women
Abstract
Objective: Weight loss and maintenance can be particularly challenging for postmenopausal women given the changes in body composition, metabolism, and lifestyle that can accompany the menopausal transition. Peptides mediating energy homeostasis (ghrelin, leptin, adiponectin, and insulin) may play an important role in the weight and body composition changes of postmenopausal women and may in turn be affected by hormone therapy (HT) use. This study examines how success with weight loss may be related to peptides mediating energy homeostasis and HT use.
Methods: The present analysis involves 200 women from a lifestyle intervention trial in overweight, postmenopausal women for whom data on the peptides ghrelin, leptin, adiponectin, and insulin were collected at 0 and 18 months. Peptide levels were compared with changes in weight from 0 to 18 and from 18 to 30 months.
Results: Baseline peptide levels were not significantly related to future weight change. From 0 to 18 months, ghrelin (P = 0.0005) and adiponectin (P ≤ 0.0001) levels increased, whereas leptin (P ≤ 0.0001) and insulin (P = 0.0003) levels decreased with increasing amount of weight loss. However, only leptin change was related to 18-30-month weight change. Women who were on HT at 0 months but discontinued by 18 months had a greater increase in ghrelin level from 0 to 18 months compared with women with continuous HT use or nonuse.
Conclusions: In overweight, postmenopausal women, changes in energy homeostasis peptides relate to both concurrent and future weight change. Future studies should continue to address how ghrelin, leptin, insulin, and adiponectin contribute to body composition changes and weight loss maintenance after menopause.
Figures

Similar articles
-
The effects of separate and combined dietary weight loss and exercise on fasting ghrelin concentrations in overweight and obese women: a randomized controlled trial.Clin Endocrinol (Oxf). 2015 Mar;82(3):369-76. doi: 10.1111/cen.12483. Epub 2014 Jun 12. Clin Endocrinol (Oxf). 2015. PMID: 24796864 Free PMC article. Clinical Trial.
-
Green Tea Extract and Catechol-O-Methyltransferase Genotype Modify Fasting Serum Insulin and Plasma Adiponectin Concentrations in a Randomized Controlled Trial of Overweight and Obese Postmenopausal Women.J Nutr. 2016 Jan;146(1):38-45. doi: 10.3945/jn.115.222414. Epub 2015 Nov 18. J Nutr. 2016. PMID: 26581683 Free PMC article. Clinical Trial.
-
Energy homeostasis and appetite regulating hormones as predictors of weight loss in men and women.Appetite. 2016 Jun 1;101:1-7. doi: 10.1016/j.appet.2016.02.153. Epub 2016 Feb 26. Appetite. 2016. PMID: 26921488 Clinical Trial.
-
Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin.Schizophr Res. 2008 Mar;100(1-3):70-85. doi: 10.1016/j.schres.2007.11.026. Epub 2008 Jan 18. Schizophr Res. 2008. PMID: 18206351 Free PMC article. Review.
-
The effectiveness of fasting regimens on serum levels of some major weight regulating hormones: a GRADE-assessed systematic review and meta-analysis in randomized controlled trial.J Health Popul Nutr. 2025 Apr 2;44(1):104. doi: 10.1186/s41043-025-00834-1. J Health Popul Nutr. 2025. PMID: 40176106 Free PMC article.
Cited by
-
Association between sedentary time and plasma leptin levels in middle-aged and older adult population in Taiwan: A community-based, cross-sectional study.Front Cardiovasc Med. 2023 Jan 9;9:1057497. doi: 10.3389/fcvm.2022.1057497. eCollection 2022. Front Cardiovasc Med. 2023. PMID: 36698957 Free PMC article.
-
Estrogen: a master regulator of bioenergetic systems in the brain and body.Front Neuroendocrinol. 2014 Jan;35(1):8-30. doi: 10.1016/j.yfrne.2013.08.001. Epub 2013 Aug 29. Front Neuroendocrinol. 2014. PMID: 23994581 Free PMC article. Review.
-
Role of estrogen in the regulation of central and peripheral energy homeostasis: from a menopausal perspective.Ther Adv Endocrinol Metab. 2023 Sep 15;14:20420188231199359. doi: 10.1177/20420188231199359. eCollection 2023. Ther Adv Endocrinol Metab. 2023. PMID: 37719789 Free PMC article. Review.
-
Serum adiponectin levels are associated with worse cognitive function in postmenopausal women.PLoS One. 2017 Dec 21;12(12):e0186205. doi: 10.1371/journal.pone.0186205. eCollection 2017. PLoS One. 2017. PMID: 29267309 Free PMC article.
-
The effects of separate and combined dietary weight loss and exercise on fasting ghrelin concentrations in overweight and obese women: a randomized controlled trial.Clin Endocrinol (Oxf). 2015 Mar;82(3):369-76. doi: 10.1111/cen.12483. Epub 2014 Jun 12. Clin Endocrinol (Oxf). 2015. PMID: 24796864 Free PMC article. Clinical Trial.
References
-
- Tchernof A, Poehlman ET. Effects of the menopause transition on body fatness and body fat distribution. Obesity Res. 1998;6:246–254. - PubMed
-
- Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors. JAMA. 2001;289:76–79. - PubMed
-
- Bjorntorp P. The regulation of adipose tissue distribution in humans. Int J Obes. 1996;20:291–302. - PubMed
-
- Chu MC, Cosper P, Orio F, et al. Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin. Am J OB/GYN. 2006;194:100–4. - PubMed
-
- Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab. 2003;88:2404–2411. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical